CONMED Corporation (FRA:EC8)

Market Cap	1.16B
Revenue (ttm)	1.15B
Net Income (ttm)	54.61M
Shares Out	n/a
EPS (ttm)	1.75
PE Ratio	21.24
Forward PE	9.36
Dividend	0.72 (1.93%)
Ex-Dividend Date	Sep 15, 2025

Volume	n/a
Average Volume	26
Open	37.20
Previous Close	37.20
Day's Range	37.20 - 38.40
52-Week Range	35.00 - 72.00
Beta	n/a
RSI	45.92
Earnings Date	Feb 4, 2026

About CONMED

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform mini...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1970
• Employees: 3,900
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: EC8

Financial Performance

In 2024, CONMED's revenue was $1.31 billion, an increase of 5.00% compared to the previous year's $1.24 billion. Earnings were $132.42 million, an increase of 105.44%.

Financial numbers in USD